Next Article in Journal
Conotoxin Gene Superfamilies
Next Article in Special Issue
Design of Chitosan and Its Water Soluble Derivatives-Based Drug Carriers with Polyelectrolyte Complexes
Previous Article in Journal
Secocrassumol, a seco-Cembranoid from the Dongsha Atoll Soft Coral Lobophytum crassum
Previous Article in Special Issue
The Influence of 1-Butanol and Trisodium Citrate Ion on Morphology and Chemical Properties of Chitosan-Based Microcapsules during Rigidification by Alkali Treatment
Article Menu

Export Article

Open AccessReview
Mar. Drugs 2014, 12(12), 6038-6057;

Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy

Western Seoul Center, Korea Basic Science Institute, Seoul 120-140, Korea
Division of Bio-imaging, Chuncheon Center, Korea Basic Science Institute, Gangwon-do 200-701, Korea
Biomedical Research Center, Korea Institute of Science and Technology, Seoul 136-791, Korea
Institute of Cell & Tissue Engineering, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea
These authors contributed equally to this work.
Authors to whom correspondence should be addressed.
Received: 9 October 2014 / Revised: 27 November 2014 / Accepted: 27 November 2014 / Published: 17 December 2014
(This article belongs to the Special Issue Advances in Marine Chitin and Chitosan)
Full-Text   |   PDF [1449 KB, uploaded 24 February 2015]   |  


Theranostics is an integrated nanosystem that combines therapeutics with diagnostics in attempt to develop new personalized treatments with enhanced therapeutic efficacy and safety. As a promising therapeutic paradigm with cutting-edge technologies, theranostic agents are able to simultaneously deliver therapeutic drugs and diagnostic imaging agents and also monitor the response to therapy. Polymeric nanosystems have been intensively explored for biomedical applications to diagnose and treat various cancers. In recent years, glycol chitosan-based nanoagents have been developed as dual-purpose materials for simultaneous diagnosis and therapy. They have shown great potential in cancer therapies, such as chemotherapeutics and nucleic acid and photodynamic therapies. In this review, we summarize the recent progress and potential applications of glycol chitosan-based fluorescent theranostic nanoagents for cancer treatments and discuss their possible underlying mechanisms. View Full-Text
Keywords: glycol chitosan; theranostics; nanosystem; fluorescence; cancer glycol chitosan; theranostics; nanosystem; fluorescence; cancer

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Rhee, J.-K.; Park, O.K.; Lee, A.; Yang, D.H.; Park, K. Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy. Mar. Drugs 2014, 12, 6038-6057.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top